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Abstract
This study describes a new multilocus variable number tandem-repeat (VNTR) analysis (MLVA) typing system for the
discrimination of Chlamydia trachomatis genovar D to K isolates or specimens. We focused our MLVA scheme on genovar E
which predominates in most populations worldwide. This system does not require culture and therefore can be performed
directly on DNA extracted from positive clinical specimens. Our method was based on GeneScan analysis of five VNTR loci
labelled with fluorescent dyes by multiplex PCR and capillary electrophoresis. This MLVA, called MLVA-5, was applied to a
collection of 220 genovar E and 94 non-E genovar C. trachomatis isolates and specimens obtained from 251 patients and
resulted in 38 MLVA-5 types. The genetic stability of the MLVA-5 scheme was assessed for results obtained both in vitro by
serial passage culturing and in vivo using concomitant and sequential isolates and specimens. All anorectal genovar E
isolates from men who have sex with men exhibited the same MLVA-5 type, suggesting clonal spread. In the same way, we
confirmed the clonal origin of the Swedish new variant of C. trachomatis. The MLVA-5 assay was compared to three other
molecular typing methods, ompA gene sequencing, multilocus sequence typing (MLST) and a previous MLVA method called
MLVA-3, on 43 genovar E isolates. The discriminatory index was 0.913 for MLVA-5, 0.860 for MLST and 0.622 for MLVA-3.
Among all of these genotyping methods, MLVA-5 displayed the highest discriminatory power and does not require a time-
consuming sequencing step. The results indicate that MLVA-5 enables high-resolution molecular epidemiological
characterisation of C. trachomatis genovars D to K infections directly from specimens.
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Introduction
Chlamydia trachomatis is the bacterium most commonly respon-
sible for sexually transmitted infections. Most of these infections
are asymptomatic and, if not treated, can lead to severe
complications and sequelae. C. trachomatis is currently divided into
19 genovars, according to the type of its major outer membrane
protein (MOMP) epitopes [1]. Genovars D to K are associated
with urogenital infections. According to epidemiological studies,
genovar E is the most prevalent, responsible more than 40% of
urogenital C. trachomatis infections in the heterosexual population
[2,3,4,5]. This genovar is also involved in 10% of the men who
have sex with men (MSM) with proctitis in France [6]. Genotyping
may reveal transmission patterns in sexual networks, play a role in
cases of sexual abuse or assaults, help to determine whether
infections are persistent or new, and aid monitoring of the
emergence of specific clones. Examples of emerging clones include
the lymphogranuloma venereum (LGV) proctitis outbreak caused
by the L2b strain among MSM and more recently, the clonal
spread of the Swedish new variant (nvCT) characterised by a 377-
bp deletion in the cryptic plasmid [3,7,8].
Early techniques for molecular typing of C. trachomatis were
developed based on the ompA gene encoding MOMP, known as
ompA genotyping [9]. This approach allows classification in
genovars corresponding to serovars, using polymerase chain
reaction (PCR) - restriction fragment length polymorphism
(RFLP), ompA gene sequencing and more recently real-time
PCR and microsphere suspension arrays [10]. Other typing
methods targeting all or parts of the genome have also been
developed. Some methods such as pulse field gel electrophoresis
(PFGE), random amplification of polymorphic DNA (RAPD) or
amplified fragment length polymorphism (AFLP) are time-
consuming or present problems in reproducibility and discrim-
ination [10]. Other techniques more reproducible and associated
with a high level of discrimination seem more promising. These
include multilocus sequence typing (MLST) [11,12,13] and a
four-loci method combining ompA sequencing and a multilocus
variable number tandem-repeat (VNTR) analysis (MLVA)
method that relies on the number of single nucleotide repeats
within three loci, called MLVA-3 in this study [8]. Among these
many methods, the MLST technique developed by Klint et al.
and the MLVA-3 method demonstrate a good degree of
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outbreak investigation [14,15].
The aim of the present study was to set up a new MLVA
scheme, automated and without a sequencing step, for C.
trachomatis urogenital genovars typing. This method was developed
on genovar E isolates and then applied on a wide range of C.
trachomatis genovar D to K isolates and specimens. To evaluate the
discriminatory power of this technique among isolates from the
same genovar, we compared it to those obtained with ompA
sequencing, the MLST technique of Klint et al. and the MLVA-3
method on 43 genovar E isolates.
Materials and Methods
Ethics statement
The present project is in compliance with the Helsinki
Declaration (Ethical Principles for Medical Research Involving
Human Subjects). The study was conducted in accordance with
the guidelines of the ‘‘Direction de la Recherche Clinique et de
l’Innovation’’ of the ethical board Bordeaux University hospital,
Bordeaux, France. All patient data were anonymously reported,
with no possibility of connecting the isolates to individual patients.
French specimens were collected as part of routine patient
management without any additional sampling, and patients
provided no objection for their samples to be used. According to
the article L1123-7 of the French code of Public Health, this study
did not need to be examined by the ethical committee ‘‘Comite ´
pour la Protection des Personnes’’ and allowed the exemption of
patient’s written or oral informed consent. Written informed
consent was obtained from French patients to collect sexual
bevahiour information following the authorization of the ethical
committee ‘‘Comite ´ Consultatif pour le Traitement de l’Informa-
tion en matie `re de Recherche dans le domaine de la Sante ´’’
(No. 10.362).
Swedish specimens from Uppsala University Hospital were
collected as part of routine diagnostics and were anonymised.
Informed consent was not needed for use of microbiological
samples in quality assurance of diagnostic methods according to
the Biobanks in Medical Care Act (2002:297). Collection and use
of anonymised samples was approved by the Regional Ethical
Review Board in Uppsala, Sweden (Dnr 2007/312).
Clinical isolates and specimens
N Genovar E. The E/Bour reference strain, 145 French C.
trachomatis genovar E clinical isolates, and 74 French and
Swedish genovar E positive-C. trachomatis clinical specimens
from 166 patients were used in this study (Table S1). All of the
French isolates and specimens were collected between 1987
and 2009 at the French national reference centre for
chlamydial infections (Bordeaux, France). These isolates and
specimens were divided into six groups (Table S1). Group I
included 103 French urogenital clinical isolates and the
corresponding specimens for 12 of them. In Group II,
concomitant urogenital isolates and specimens collected from
17 French patients were analysed. Group III consisted in
French urogenital sequential isolates and specimens collected
from 12 patients. Group IV consisted in French C. trachomatis-
positive specimens collected before and after antibiotic
treatment from five patients with an interval of 8–10 weeks
between the two specimen collections. Group V was composed
of the unique nvCt isolate identified in France [16] and 20
Swedish specimens collected in 2009 at the Uppsala University
Hospital (Uppsala, Sweden) and containing the recently
described nvCT strain [3]. Finally, Group VI contained 10
male and one female anorectal isolates and specimens collected
in France from 2005 to 2010.
The C. trachomatis isolates were cultured on McCoy cells as
previously described [9].
N Non-E genovar. Reference strains D/UW-3/Cx, Da/TW-
448/Cx, F/IC-Cal-3, G/UW-57/Cx, H/UW-43/Cx, I/UW-
12/Ur, Ia/UW-202/Cx, J/UW-36/Cx and K/UW-31/Cx
were analysed. Then, we genotyped 85 C. trachomatis-positive
specimens (54 urogenital and 31 anorectal) belonging to
genovars D, Da, F, G, H, I, Ia, J and K (Table S2). Specimens
were collected between 1994 and 2010 at the French national
reference centre for chlamydial infections (Bordeaux, France).
DNA isolation
DNA was extracted from clinical specimens or bacterial cell
cultures using the MagNA Pure LC DNA Isolation Kit I (Roche,
Meylan, France) according to the manufacturer’s instructions.
MLVA-5 analysis
VNTR markers were identified in the sequenced genomes of C.
trachomatis A/HAR-13 [17], D/UW-3/Cx [18], L2 434/Bu, L2b/
UCH-1/proctitis [19] and E/Sweden2 [20] by the Microorgan-
isms Tandem Repeats database and the Tandem Repeats Finder
program which is available at http://minisatellites.u-psud.fr. To
improve polymorphic tandem repeat (TR) identification, loci were
chosen on the basis of matches of at least 80% between the DNA
sequences of the repeat units. A total of 202 TRs were selected and
designated by the letters Ct followed by a number corresponding
to the position on the C. trachomatis D/UW-3/Cx genome. To
screen for variability in the number of TRs, PCR primers
targeting the regions flanking TR loci were designed and tested on
a set of 19 genovar E C. trachomatis isolates, including the E/Bour
reference strain, eight cervix isolates, five male urethral isolates,
four anorectal isolates and one isolate from peritoneal fluid,
collected from 1987 to 2008 from different geographical areas.
Each locus was amplified individually and analysed by conven-
tional agarose gel electrophoresis. To confirm that length
polymorphisms were the result of repeat copy number variations,
the PCR products were purified using Wizard PCR Preps DNA
Purification System (Promega, Charbonnie `res-les-Bains, France)
and sequenced using fluorescence-labelled dideoxynucleotide
technology, according to the manufacturer’s instructions (Applied
Biosystems, Courtaboeuf, France). Based on this approach, five
VNTR markers were selected for full assessment.
The five VNTR markers ultimately selected for MLVA-5 were
multiplexed in two solutions: a triplex PCR was used to amplify
the markers Ct-51, Ct-531 and Ct-1025 and a duplex PCR was
used to amplify the markers Ct-719 and Ct-1035. Amplifications
were performed with a Mastercycler ep gradient S apparatus
(Eppendorf, Hamburg, Germany) in a final volume of 25 ml. The
reaction mixtures contained 16Qiagen PCR buffer with 1.5 mM
MgCl2, 0.2 mM deoxynucleotide triphosphate, 3 mM MgCl2,
0.625 U of Hot Start Taq DNA polymerase (Qiagen, Hilden,
Germany), 0.125 mM of each primer and 1 ml of template DNA
for clinical isolates or 2.5 ml of template DNA for clinical
specimens. Forward primers were fluorescently labelled at the
59 end using 4,4,7,29,49,59,79-hexachloro-6-carboxy-fluorescein
(HEX), 6-carboxyfluorescein (FAM; Eurogentec, Angers, France)
or NED (29-chloro-59-fluoro-79,89-fused phenyl-1,4-dichloro-6-
carboxyfluorescein; Applied Biosystems), depending on the locus
to be amplified (Table 1). Both multiplex solutions were run under
MLVA for Genovar E and Non-E Chlamydia trachomatis
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of 95uC for 1 min, 60uC for 1 min and 72uC for 1 min and a final
extension at 72uC for 10 min. For clinical specimens, the cycling
conditions were similar, except that amplification required 40
cycles. Prior to GeneScan analysis, 0.3 ml of GeneScan ROX 500
size standard (Applied Biosystems) was added to 1 ml of each PCR
product. After heat denaturation for 5 min at 95uC, the fragments
were separated using an ABI 3130 Genetic Analyzer (Applied
Biosystems). The GeneScan data were subsequently analysed using
GeneMapper software (version 3.7; Applied Biosystems) to
perform sizing and to calculate the number of repeats in the
PCR fragments. Each locus was identified according to colour
fluorescence. An allele number string, based on the number of
repeats at each locus, was assigned to all isolates. The calculated
numbers of repeats were imported in BioNumerics (version 6.1;
Applied Maths) for further cluster analysis.
Other typing techniques for C. trachomatis
Three methods (ompA sequencing, MLST and MLVA-3) relying
on sequencing of selected genes were performed on 43 genovar E
isolates (in bold in Table S1) belonging to 15 MLVA-5 types. This
group included all anorectal isolates, the nvCT and extragenital
isolates, isolates with a unique or infrequent MLVA-5 type, isolates
belonging to the three main MLVA-5 types and concomitant or
sequential isolates from the same patient.
For ompA sequencing, a 1085-bp fragment of this gene was
amplified by PCR using CT1 and CT5 primers [9]. Sequence data
of the new allelic variant is avalaible under GenBank accession
number JN192145.
For the MLST method, five regions of the C. trachomatis
genome (hctB, CT058, CT144, CT172 and pbpB) were amplified
as described by Klint et al. [12]. The PCR products were purified
and sequenced as described above. Sequences were submitted to
the Uppsala C. trachomatis MLST database (http://mlstdb.bmc.
uu.se) and compared with previously described allele variants to
determine the sequence type (ST) of the isolates. Concerning the
new allelic variants and ST assignment, we used the numbering
system developed originally in 2007 by Klint et al.. We described
11 new allelic variants: hctB-54 (GenBank accession number
HQ37008), hctB-55 (GenBank accession number HQ37009),
hctB-56 (GenBank accession number JN192138), hctB-57 (Gen-
Bank accession number JN192137), hctB-58 (GenBank accession
number JN192139), hctB-59 (GenBank accession number
JN192140), CT058-46 (GenBank accession number JN192144),
CT058-47 (GenBank accession number JN192143), CT172-17
(GenBank accession number HQ873007), pbpB-54 (GenBank
accession number JN192141) and pbpB-55 (GenBank accession
number JN192142). We described 12 new STs, ST 222 to 233
(Table 2).
For the MLVA-3 method, three loci (CT1291, CT1299 and
CT1335) were amplified as described by Perdersen et al. [8]. The
assignment of the MLVA-3 type was carried out according to the
rules described by Pedersen et al. [8].
Data analysis
The polymorphism index of individual or combined VNTRs
was calculated using the Hunter-Gaston discriminatory index
(HGDI) [21]. For MLVA-5, the HGDI was calculated on 146
genovar E and 94 non-E genovar isolates and specimens that were
epidemiologically unrelated. Data obtained from MLVA-5 for
genovar E isolates and specimens were converted into character
data sets and analysed using BioNumerics software. A minimum
spanning tree (MST) was generated to visualise of the relationships
between large numbers of isolates in a single compact image. The
MST was created based on the categorical coefficient and a
priority rule consisting of the highest number of single-locus
variants.
For the comparison of the molecular typing methods, the HGDI
if each technique was calculated on 38 genovar E isolates that were
epidemiologically unrelated (for concomitant or sequential isolates
from the same patient, only the first isolate was included). Data
obtained from each method were analysed using BioNumerics
software. A MLVA-5 dendrogram including the results of other
typing methods was constructed using the categorical coefficient
and the unweighted-pair group method using arithmetic averages
(UPGMA) analysis.
Results
Identification of VNTRs for MLVA typing
Amplification of 202 loci from the E/Bour reference strain and
18 genovar E isolates showed that only five loci were polymor-
phic with different allele sizes. A total of 195 markers were
Table 1. Oligonucleotide primers used for MLVA-5.
Primer name
a Dye sequence (59R39)
Ct-51-fwd……………… HEX-TGGGAGTACAAAAGAAATGCAG
Ct-51-rev……………… GAAGCAGCTACACGTCCACA
Ct-531-fwd……………. NED-CCTCATCAAGCGATCATATCC
Ct-531-rev……………… GCCGAATACACCCTCGTTAC
Ct-719-fwd……………. HEX-CTCGCAACCCCAGAGTCG
Ct-719-rev…………….. GTGTTTTGTTATGTGTGGTAGGCT
Ct-1025-fwd…………… 6-FAM-CCATCGTCGAGCCATATCTT
Ct-1025-rev……………. TCTTCCGTCCCCTCCTCTT
Ct-1035-fwd…………… 6-FAM-CCGGAGCAGGCGAAGTG
Ct-1035-rev……………. CCTTTCCGAGCATCACTAACTG
afwd, forward primer; rev, reverse primer.
doi:10.1371/journal.pone.0031538.t001
Table 2. Description of the 12 new MLST sequences types.
hctB CT058 CT144 CT172 pbpB ST
12 6 17 22 2 2
59
a 27254 223
58 1 9 721 2 2 4
21 2 7 2 1 225
56 1 9 721 2 2 6
57 2721 2 2 7
54 46 721 2 2 8
11 9 7 17 12 2 9
5 1 9 721 2 3 0
55 1 9 721 2 3 1
1 2621 2 3 2
12 6 2 55 233
na
b 47 622 n d
c
anew allelic variants are indicated in bold.
bna: no amplification.
cnd: not determined.
doi:10.1371/journal.pone.0031538.t002
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analysis since the sequence variability observed between isolates
was not related to a variation in repeat number but to insertions/
deletions. The five VNTRs were distributed around the genome
from nucleotide positions 51543 to 1035380 in the C. trachomatis
D/UW-3/Cx reference strain (Table 3). The PCR products
ranged in size from 151–604 bp in the C. trachomatis E/Bour
reference strain. Four of the five VNTRs were located in open
reading frames (ORFs). The markers Ct-51, Ct-531 and Ct-1035
were located in the hctB gene encoding the histone-like protein
Hc2, the tarp gene encoding a translocated actin-recruiting protein
and the pmpH gene encoding a polymorphic outer membrane
protein, respectively. The marker Ct-1025 was located in an ORF
encoding a hypothetical protein. The fifth VNTR, Ct-719, was in
an intergenic region. Characteristics of each VNTR marker are
presented in Table 3. The sizes of the unit repeats ranged from
3 bp for Ct-719 and Ct-1025 to 150 bp for Ct-531. Sequencing of
the PCR products of different sizes at each of the five loci from
each of the 19 screening isolates confirmed the sizes and sequences
of the individual VNTR loci.
The use of fluorescently labelled primers in a triplex PCR
associating Ct-51, Ct-531 and Ct-1025 and a duplex PCR,
including Ct-719 and Ct-1035 and adapted to capillary electro-
phoresis, facilitated the interpretation of the results in contrast to
agarose gel electrophoresis. Using GeneMapper software, all loci
were clearly identified on electropherograms according to their
size ranges and colours, and the amplicon sizes allowed the
determination of the repeat number.
Specificity and stability of the MLVA-5 scheme
The specificity of MLVA-5 assay was investigated by conduct-
ing PCR on 15 C. trachomatis-negative clinical specimens and DNA
from the following bacterial species: Escherichia coli, Enterococcus
faecalis, Klebsiella pneumoniae, Gardnerella vaginalis, Candida albicans,
Lactobacillus spp., C. pneumoniae, Mycoplasma hominis, M. genitalium,
Ureaplasma spp., Neisseria gonorrhoeae, Staphylococcus aureus and S.
epidermidis. No amplification was observed for all of the non-C.
trachomatis isolates and specimens, thereby confirming the specific-
ity of the assay.
The E/Bour reference strain and four clinical C. trachomatis
genovar E isolates (IE783, IE802, IE874 and IESL52) belonging to
four different MLVA-5 types were used in the stability study.
Each isolate was serially passaged 10 times on McCoy cells to
determine the stability of each locus before and after passaging.
The DNA was subsequently extracted and double-strand
sequenced to identify the number of repeats in each locus.
Analysis of the five isolates resulted in identical MLVA-5 type for
all markers.
MLVA-5 typing of clinical isolates and specimens
The five VNTRs were efficiently amplified for all 314 C.
trachomatis isolates and specimens tested, including those for which
culture could not be achieved. Analysis of the results revealed 38
MLVA-5 types, from 01 to 38 (Table 4). The HGDI of the
MLVA-5 scheme was 0.919.
Genovar E clinical isolates and specimens. Genovar E
i s o l a t e sa n ds p e c i m e n sw e r eo f2 5M L V A - 5t y p e s ,f r o m0 1t o2 5( T a b l e
S1). Three MLVA-5 types, 02, 11 and 13, included 63% of all genovar
E isolates and specimens tested (Figure 1). In 12 cases (5%), one unique
MLVA-5 type was observed for a single patient. The size variation of
the amplicons was in exact multiples of the repeats, except for the
marker Ct-51 for which partial repeats were found (Table 4). The
marker Ct-51 showed five different allele sizes, with repeat copy
numbers ranging from 2.5 to 4.5. The markers Ct-531 and Ct-1025
displayed three different allele sizes, and the markers Ct-719 and Ct-
1035 resulted in two different-sized PCR products. The marker Ct-531
was the most homogeneous with 140 isolates or positive specimens
harbouring two repeat units of 150 bp. This was reflected by the
diversity index of each VNTR as estimated by the HGDI, yielding a
value of 0.546 for the most discriminatory marker (Ct-1025) and a
value of 0.080 for Ct-531, which is the least discriminatory marker.
The overall discriminatory index for MLVA-5 was 0.839.
The reliability of MLVA-5 was affirmed by the results obtained
from typing direct clinical specimens and that of the corresponding
isolate (Group I) as they all resulted in the same MLVA-5 type per
patient (Table S1).
In Group II, no intra-individual variation of the MLVA-5 type
was found for the 17 patients with concomitant isolates or
specimens. In Group III, sequential isolates and specimens from
each of the 11 patients revealed an identical MLVA-5 type
suggesting a persistent C. trachomatis infection or a possible
reinfection by an untreated partner (Table S1). For one patient,
three concomitant isolates from the female locations cervix,
peritoneal fluid and endometrium obtained on the day of testing
shared the MLVA-5 type 02, while the cervix isolate obtained
three years later belonged to the MLVA-5 type 13, suggesting a
new C. trachomatis infection (Table S1).
For five patients (Group IV) who had been treated with single-
dose azithromycin and in whom C. trachomatis could subsequently
be detected, all patients showed an identical MLVA-5 type before
and after treatment.
In Group V comprising the nvCT isolate obtained in France
and 20 Swedish nvCT specimens, all displayed the unique MLVA-
5 type 14, thereby confirming a clonal origin (Figure 1). In Group
VI, of the 11 anorectal isolates and specimens, nine were of the
MLVA-5 type 21 and these were all from MSM, while two other
anorectal specimens, derived from a woman and a bisexual man,
were of the MLVA-5 type 13. It should be noted that one
Table 3. Characteristics of the five VNTR markers.
Name
Nucleotide
position
a (bp)
Locus (protein no. in the
genome sequence)
Repeat size
(bp)
% identity between
VNTRs
Locus size
(bp)
Ct-51 51543 hctB gene (CT046) 108 91 307–604
Ct-531 531356 tarp gene (CT456) 150 98 294–594
Ct-719 719983 Intergenic 3 100 206–209
Ct-1025 1025053 Hypothetical protein (CT868) 3 94 244–253
Ct-1035 1035358 pmpH gene (CT872) 6 83 144–150
aPosition (59 end) on the C. trachomatis D/UW-3/Cx genome sequence.
doi:10.1371/journal.pone.0031538.t003
MLVA for Genovar E and Non-E Chlamydia trachomatis
PLoS ONE | www.plosone.org 4 February 2012 | Volume 7 | Issue 2 | e31538additional isolate obtained from the male urethra displayed the
MLVA-5 type 21 (Table S1).
Finally, the genetic relationships investigations showed no
obvious link between the MLVA-5 type and the isolate or
specimen year of collection or patient
Non-E genovar specimens. Non-E genovar specimens were
of 18 MLVA-5 types, including 13 new MLVA-5 types (26 to 38)
compared to the genovar E isolates and specimens (Table 4). Seven
new MLVA-5 types were only constituted of anorectal specimens
and four of them were of only a single specimen (Table S2). Three
MLVA-5 types, 09, 17 and 32 included half of all non-E genovar
specimens analysed. Interestingly, no size variationwasobserved for
the Ct-719, with only one repetition for all specimens tested. The
Ct-51 displayed only three different allele sizes, with repeat copy
numbers ranging from 2.5 to 3.5. As described for genovar E, the
Ct-531 and the Ct-1025 displayed three different sizes and the Ct-
1035 two different-sized PCR products. The Ct-1025 was also the
most discriminating marker with an HGDI equal to 0.614.
Table 4. Number of repeat units of the five VNTR markers in 220 genovar E and 94 non-E genovar C. trachomatis isolates and
clinical specimens.
MLVA-5 type No. of repeats at the following VNTR loci No. of isolates by MLVA-5 type
Ct-719 Ct-1035 Ct-51 Ct-531 Ct-1025 genovar E non-E genovar
0 1144 . 5 236 0
0 2244 . 5 234 4 0
0 3243 . 5 232 0
0 4244 . 5 131 0
0 5244 . 5 263 0
0 6242 . 5 262 0
0 7232 . 5 231 0
0 8143 . 5 234 6
0 9143 . 5 332 1 2
1 0134 . 2 264 0
1 1133 . 5 264 0 3
1 2134 . 5 163 0
1 3134 . 5 265 5 0
1 4132 . 5 262 1 0
1 5132 . 5 362 1
1 6142 . 5 261 0
1 7143 . 5 261 1 7
1 8144 . 5 261 0
1 9134 . 5 238 0
2 0234 . 5 231 0
2 1134 . 5 241 0 0
2 2144 . 5 242 0
2 3243 . 5 262 0
2 4133 . 7 262 0
2 5243 . 5 332 0
2 6143 . 5 340 1 0
2 7143 . 5 360 9
2 8143 . 5 240 4
2 9143 . 5 140 1
3 0142 . 5 340 3
3 1142 . 5 330 2
3 2133 . 5 360 1 8
3 3142 . 5 360 2
3 4142 . 5 130 1
3 5142 . 5 240 1
3 6143 340 2
3 7143 330 1
3 8143 . 5 130 1
doi:10.1371/journal.pone.0031538.t004
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MLVA-3 for molecular typing of genovar E C. trachomatis
isolates
Forty-three genovar E isolates were included in an evaluation
where MLVA-5 was compared to ompA sequencing, the MLST
developed by Klint et al. and MLVA-3 [8,12].
The MLVA-5 differentiated into 15 genotypes. OmpA sequenc-
ing resulted in two genotypes where all isolates except one
displayed identical sequences compared to that of the E/Bour
reference strain. The IE828 isolate harboured a silent ARG
mutation at nucleotide position 420 in the constant domain C2 of
the ompA gene.
MLST analysis resulted in 17 STs. Complete MLST profiles
were obtained for 42 out of the 43 isolates tested, as the hctB gene of
one isolate could not be amplified. We identified six new allelic
variants for the hctB gene, two for the CT058 and pbpB genes and
one for the CT172 gene. MLST analysis resulted in the description
of 12 new allelic STs, eight of which corresponded to only one
isolate (Table 2). One third of the isolates were of ST-56 (Figure 2).
Using MLVA-3, eight MLVA-3 types were assigned. More than
two thirds of the isolates were of the two MLVA-3 types 8.5.1 (25
isolates) and 8.6.1 (11 isolates) (Figure 2). We identified one new
MLVA-3 type, 7.6.1, for the IE392 isolate.
All anorectal isolates shared the MLVA-5 type 21, ST-56 and
MLVA-3 type 8.6.1 except for the IECV319 isolate (Figure 2). The
latter harboured the MLVA-5 type 21 and a new ST, ST-228 (as
well as the cervical isolate IE466), and the unique MLVA-3 type
6.5.1, already described for urogenital isolates [14]. Although the
MLVA-5 type 21 was only found among all anorectal isolates
except one, ST-56 and MLVA-3 type 8.6.1 were commonly
detected among urogenital isolates (10 and six urogenital isolates,
respectively). Therefore, MLVA-5 appears to be more efficient at
discrimination of clusters.
One patient probably harboured a new C. trachomatis infection
three years after the initial visit because sequential isolates IE358
and IE600 displayed the different MLVA-5 types 02 and 13,
respectively, as well as distinct STs and MLVA-3 types. In
contrast, the concomitant isolates IE874 and IE875, IE357 and
IE358 shared the same Chlamydia genotype regardless of the
molecular typing method used (Fig. 2).
The HGDI, calculated on 38 isolates that were epidemiolog-
ically unrelated, was 0.913 for MLVA-5, 0.860 for MLST and
0.622 for MLVA-3 (Table 5). The congruence between MLVA-5
and MLST was 60.3%, while it was lower (22.5%) between
MLVA-5 and MLVA-3. An identical HGDI of 0.949, with the
same number of 20 different genotypes described, was found when
MLVA-5 and MLST or MLVA-5, MLST and MLVA-3 were
combined into one analysis (Table 5).
Discussion
In this study, we present a new MLVA-based molecular typing
system for the discrimination of genovar E and other genovar D to
Ko fC. trachomatis strains. MLVA-5 is a reproducible and fast
technique that does not require a sequencing step and can be
standardised, thereby facilitating large-scale molecular epidemio-
logical investigations. The application of multiplex PCR and
Figure 1. MST of the MLVA-5 types of genovar E C. trachomatis isolates and positive specimens. Each circle denotes a particular MLVA-5
type. The size of the circle is proportional to the number of isolates or specimens belonging to the indicated MLVA-5 genotype. The distance
between neighbouring genotypes is expressed as the number of allelic changes and is outlined by short bold lines for one change. No cluster is
emphasised as shown by the distance, equal to one, between neighbouring genotypes.
+ MLVA-5 types encompassing anorectal isolates and
specimens.
w MLVA-5 type containing nvCT isolate and specimens.
doi:10.1371/journal.pone.0031538.g001
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throughput analysis and allows easier interpretation of results in
contrast to agarose gel electrophoresis, particularly for VNTRs
with a small number of repeat units.
C. trachomatis displays remarkable genome sequence similarity
and synteny, considering the different diseases and tissue tropism
exhibited by the different genovars. Of 202 TR loci identified, only
five were polymorphic on genovar E isolates, confirming the high
Figure 2. Clustering dendrogram of 43 genovar E C. trachomatis isolates typed by four molecular methods. The order in which the
isolates are listed, from top to bottom, is based on the MLVA-5 dendrogram (left side of the figure). The dendrogram was constructed using a
categorical coefficient and UPGMA clustering. Concomitant and sequential isolates from the same patients are highlighted in grey and are
underlined, respectively. The MLVA-5 type 21, which included all anorectal isolates, is outlined in black. nd, not determined.
doi:10.1371/journal.pone.0031538.g002
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were found in C. psittaci among 20 TRs and five VNTRs were
identified among 34 TRs for C. abortus [22,23].
The marker Ct-51, located in the hctB gene, showed six different
allele sizes with a repeat copy number ranging from 2.5 to 4.5. This
gene was one of the targets of the MLST technique developed by
Klint etal..AllofthenvCT isolatesdisplayedthe allelicvariant hctB-
21 with MLST and a 2.5 repeat for the marker Ct-51 with MLVA-
5. Other genovar E isolates shared one of these two allelic variants,
although they did not have the plasmid deletion. The marker Ct-
531, located in the tarp gene, was the least discriminatory of the
VNTRs identified for the genovar E. These results confirm the data
of Lutter et al., who showed that among 14 urogenital genotype E
clinical isolates collected from different areas, 12 had Tarp
sequences identical to that of the E/Bour reference strain [24].
However, the marker Ct-531 allowed distinction of the nvCT
isolates from the other isolates harbouring identical allelic profiles
on the four other VNTRs. Although the Ct-719 displayed two allele
sizes among genovar E isolates, this marker was monomorphic
amongtheurogenitalnon-Egenovarspecimensanalysed.However,
more specimens need to be tested to confirm these results.
The stability of the method was assessed in vitro by ten-passage
culturing for five isolates and in vivo using sequential isolates and
specimens from 11 patients on a time interval of 1–28 months.
Moreover, in 17 cases, concomitant specimens or isolates
harboured identical MLVA-5 types. Taken together, both the in
vitro and the in vivo data showed no MLVA-5 type variation over
time or within individuals, implying that our MLVA-5 scheme is
genetically stable for short-term applications.
In our study, nine of the 11 anorectal C. trachomatis genovar E
isolates displayed the same unique MLVA-5 type 21. All of these
patients were MSM and were mainly from the same region in
France, suggesting clonal spread of a strain. Interestingly, the
available genome of the E/150 rectal isolate shared the MLVA-5
type 21 [25]. Unfortunately, no information about the sexual
behaviour and geographical origin of the patient from whom the
E/150 strain was isolated was available. Using whole-genome
sequencing along with comparative genomics, Jeffrey et al. showed
that there were only 1130 substitutions and 54 insertions or
deletions between the E/150 male rectal and the E/11023 cervical
genovar E isolates [25]. In their work, the authors identified three
ORFs that were statistically correlated with rectal tropism only in
genovar G, while none of these ORFs were statistically associated
with rectal tropism in genovar E isolates. We genotyped six
anorectal isolates from MSM using MLST and MLVA-3. All of
the isolates except one belonged to ST-56 and MLVA-3 type
8.6.1. These two genotypes were associated with both anorectal
and urogenital isolates, while the MLVA-5 type 21 was only
associated with all anorectal isolates except one. Indeed, one male
urethral isolate displayed the MLVA-5 type 21, but the sexual
behaviour of the patient was unknown. The association of a
unique MLVA-5 type with anorectal genovar E specimens from
MSM must be confirmed by further analysis of additional
specimens. In contrast, the 31 anorectal non-E genovar specimens
were distributed among 15 MLVA-5 types and there was no
relation between MSM anorectal specimens tested and a MLVA-5
type.
Our results confirmed a clonal spread of the nvCT, in
accordance with other reports [3,8]. The nvCT specimens tested
in our study were previously genotyped by MLST, and all of them
displayed the same unique MLST profile ST-55 and an identical
ompA sequence to that of the E/Bour reference strain [3]. All of
these specimens also displayed the same unique MLVA-5 type 14.
Recently, using ompA genotyping, it was shown that repeated C.
trachomatis infections in adolescent women were due to reinfection
in 54% of the cases, treatment failure in 14% of the cases and
persistence without documented treatment in 2% of the cases [26].
In our study, we obtained, C. trachomatis-positive specimens from
five patients before and after treatment and these were for each
patient of an identical MLVA-5 type, suggesting treatment failure
and persistence of infection. However, we could not exclude
recontamination as no information on partner treatment was
available.
In several studies, the molecular epidemiology of chlamydial
infections was based on analysis of the ompA gene. However, to
discriminate within genotypes, a single marker is inadequate
because of the risk of recombination events [5,11]. Therefore,
more discriminating molecular techniques are needed
[8,11,12,13]. Klint et al. developed an MLST scheme targeting
the five most variable regions of the chlamydial genome, while
Pedersen et al. developed an MLVA method based on single
nucleotide repeats, which are a type of VNTR, within three loci
combined to ompA sequencing [8,12]. MLST and MLVA-3 are
time-consuming techniques that require a sequencing step. In our
work, we compared MLVA-5 to ompA sequencing, MLST and
MLVA-3 for 43 genovar E isolates. Results from ompA sequencing
confirmed a high level of conservation of genovar E isolates
[2,5,12,27]. Using MLST, 42 isolates exhibited17 STs, of which
12 were new. For one isolate, an ST could not be assigned because
we failed to amplify one target region. Using MLVA-3, all isolates
were amplified, and we described only eight MLVA-3 types of
which one was new. It should be noted that it is difficult to
interpret the MLVA-3 results, as more than 11 single nucleotide
repeats can be observed at one single locus, associated with the
strong probability that the DNA polymerase, routinely used in
PCR, may have generated sequence errors [14,28]. Furthermore,
the stability of this technique has not been fully assessed [8]. Our
data were in agreement with those reported by Bom et al. who
observed that for 13 genovar E specimens, the number of STs
described (eight) was higher than the number of MLVA-3 types
(five) [14]. Moreover, also in our study, nearly 60% of the STs that
were identified were new. In contrast, the results obtained by
Ikryannikova et al. conflict with ours and those of Bom et al., as for
12 genovar E isolates, five MLVA-3 types but only two STs were
described [2].
According to HGDI values, MLVA-3 showed the lowest
discriminatory power (0.622), in contrast to other studies that
found a better HGDI for genovar E, ranging from 0.782 to 0.902
[2,5,8,29], while MLVA-5 and MLST presented similar HGDI
Table 5. Discriminatory index for the molecular typing
methods, single or combined, on genovar E C. trachomatis
isolates.
Method HGDI
a
MLVA-5 0.913
MLST 0.860
MLVA-3 0.622
MLVA-5+MLVA-3 0.925
MLST+MLVA-3 0.929
MLVA-5+MLST 0.949
MLVA-5+MLST+MLVA-3 0.949
aHGDI, Hunter-Gaston discriminatory index. The HGDI was calculated on 38
isolates that were epidemiologically unrelated.
doi:10.1371/journal.pone.0031538.t005
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be 1.00, but in practice, it should be at least 0.90–0.95 for a typing
system to be relatively optimal [30]. A combination of MLVA-5
and MLST resulted in the highest HGDI (0.949).
The application of the five VNTRs identified within genovar E
permitted to describe 13 additional MLVA-5 types among non-E
genovar specimens. However, to optimize the method, it would be
interesting to look for new VNTRs for non-E genovar.
In summary, MLVA-5 has been developed for the genovar E C.
trachomatis and used to type a large collection of French isolates and
C. trachomatis-positive specimens belonging to genovar E and
urogenital non-E genovars. Our findings show that MLVA can be
used to discriminate between C. trachomatis isolates and can be
directly applied to clinical specimens, thereby providing a high-
resolution molecular epidemiological tool. Accordingly, the overall
performance of the MLVA-5 assay would facilitate large-scale
molecular epidemiological investigations of sexually transmitted C.
trachomatis infections.
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